久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Riding opportunities in 'huge unmet needs'

By Zhun Wenqian | China Daily | Updated: 2017-03-31 08:22

Riding opportunities in 'huge unmet needs'

David Ricks, CEO of US pharmaceutical company Eli Lilly and Co. [Photo provided to China Daily]

David Ricks shapes US-based pharmaceutical giant Eli Lilly's China market strategy involving local partnerships, focus on chronic conditions

David Ricks is a pharma battle-scarred veteran, having been with Eli Lilly and Co for 20 years. Before he rose to CEO this year, he spent long, sensitive years heading the US giant's bio-medicine business when it faced patent expirations on key medicines.

"That period significantly reduced our revenues, but we had a great team that worked through the challenge," he said.

"Today the bio-medicine business is growing again with new medicines in immunology and more potential medicines in late-stage development."

One of the world's oldest pharmaceutical firms, Lilly established its China branch in Shanghai in 1918. Now China serves as one of its top three markets, besides the United States and Japan. The CEO said the company is firmly committed to China and plans to further strengthen its presence in the country.

Recently, he spoke to China Daily about its expansion plans in the mainland and other emerging opportunities. The following are edited excerpts from the interview:

Do you have confidence in the China market? How do you view your growth potential in China?

The Chinese pharmaceutical market is one of the largest in the world and it continues to grow at a healthy pace. We are optimistic about the development of the China region.

We will focus on our existing product portfolio, particularly in chronic diseases, such as cancer and diabetes, where we have a competitive edge in the China market. The growth of these two markets is remarkably rapid, due to the aging population and urbanization in China. There are huge unmet needs, which bring huge opportunities for Lilly in China.

Lilly China expects to launch around 31 new compounds and new indications within 10 years, including 11 in oncology, eight in diabetes and cardiovascular and 12 in our bio-medicines organization.

Do you have any investment plans in China in the next few years?

Lilly's strategic priorities for 2020 are to build a network of China partnerships, engage and develop people, lead in ethics and compliance, transform promotional models and focus on execution excellence, maintain and accelerate access.

We remain focused on implementing our growth plans, which include building a new insulin cartridge-filling plant in Suzhou, Jiangsu province, with an investment of 2 billion yuan ($290 million). We will also expand external alliances with different partners, such as Innovent, Wuxi AppTec, Hutchison.

Do you plan to increase your R&D efforts in China?

We have internal work and external partnerships at every stage of the R&D process and our focus is to speed up access to available innovation in China. Our R&D center in Shanghai focuses on diabetics in China and exploring new fields of treatments in diabetes.

Besides, our Shanghai-based Lilly Asia Ventures was launched in 2008 and it is one of the most active life science investors in China with 30 active portfolio companies. It has built a great portfolio in both life science services and biotech. It is also the only pharma corporate venture capital investor with a local presence. This year, we're looking toward to close our Lilly Asia Ventures Fund IV.

We are encouraged by the recent signs of improvements at China's Food and Drug Administration and we look forward to partnering with Chinese authorities to further accelerate new cures for Chinese patients. Our business model is to provide new and innovative medicines to patients, rather than profiting from drugs with expired patents.

Do you have any expansion plans or business strategies in accordance with the Belt and Road Initiative?

We have been paying close attention to the development of the Belt and Road Initiative and we have been glad to see the major achievements made to date. We will let you know when our plans can be disclosed.

What's your view on the impact of globalization?

Lilly is a global company. In fact, about half of our business is outside the US. For some time now, I've been directly involved in the company's efforts on trade. We believe that healthy trade agreements create a gateway for innovation and collaboration. That requires balanced, win-win trade agreements that protect intellectual property and ensure fair and transparent regulation and access to the market. Such agreements, in turn, help innovators like Lilly more efficiently create and deliver products that enhance life.

What was your biggest achievement in China when you served as general manager there?

Elevating China to a top corporate priority and driving investment and growth. When I arrived in China in 2008, China had been managed as part of an Asian region and managed for shorter-term results. We were able to change both of those things.

What's your management style like?

Leadership for me is based on a shared purpose. Building a team that has high degrees of trust and honesty is core to creating a shared commitment to our goals. As a coach of top executives, I believe that everyone can improve and we are all capable of much more than we think, so I maintain a high level of support. But I also have high expectations of my teammates. I also believe that one has to lead by example when things get hard-this is not only required for leadership but also for strengthening team trust.

What's the best way to break the ice with Chinese businessmen?

People are people around the world and it's critical to connect on a personal level. Sharing a meal and a drink, understanding where we are both from and what we have in common, are always successful methods for me.

How do you handle hardships and setbacks?

Disappointments and risks are part of our business. The most important thing is to learn from mistakes and avoid repeating them. I try to look for the lessons rather than dwell on the disappointment and, while accountability is an important value, try to determine whether our team leaders made well-informed decisions and whether execution was sound.

We can learn from each of these steps-and sometimes in the difficult business of drug discovery, we can do virtually everything under our control extremely well and still fail. Disease can be a challenging opponent. But if we look forward, persist and adapt, we often find a way to improve the lives of patients.

How do you spend the weekend amid your busy schedule? What are your hobbies?

I enjoy the outdoors and spending time with my family. My wife and I have two sons and a daughter. With two kids in high school and a fifth-grader, when I'm not at work I'm mostly a dad-watching soccer games and cross-country meets and taking Scouts on backpacking trips.

What kind of a green lifestyle do you have?

My favorite leisure activities are outdoors and I have a personal reverence for the natural world. I'm proud to work for a company that's committed to environmental stewardship and sustainability in our operations. Making medicines requires the use of valuable resources such as energy, water and raw materials. Lilly takes a broad approach to understanding and managing our environmental impact and we're continuously looking for ways to improve our performance, like increasing energy efficiency and reducing greenhouse gas emissions.

CV

Age: 49

Career:

2017 onwards: President and CEO of Eli Lilly

2012-2016: President of Lilly Bio-Medicines

2009-2012: President and general manager of Lilly USA

2008-2009: President and general manager of Lilly China

2005-2008: General manager of Lilly Canada

Education:

1996: MBA from Indiana University;

1990: BS from Purdue University

Family: Married with three children

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    国产精品另类一区| 国产日韩欧美不卡| 麻豆精品视频在线| 欧美成人乱码一区二区三区| 国产在线精品不卡| 国产精品欧美综合在线| 色菇凉天天综合网| 午夜影院在线观看欧美| 日韩欧美中文一区二区| 国产成人综合在线| 亚洲欧美激情小说另类| 91精品午夜视频| 国产一区二区看久久| 亚洲天堂av一区| 欧美日韩精品欧美日韩精品一| 日本成人在线不卡视频| 国产欧美日韩麻豆91| 色菇凉天天综合网| 麻豆一区二区三区| 中文av一区二区| 欧美亚洲丝袜传媒另类| 久久99精品国产麻豆不卡| 中文一区在线播放| 欧美日韩在线综合| 国产精品一卡二卡| 亚洲综合色在线| 欧美xxxxxxxx| www.亚洲色图| 日韩精品一级中文字幕精品视频免费观看| 久久综合狠狠综合久久激情| 色婷婷综合五月| 久久99久久久欧美国产| 亚洲欧美日韩国产综合在线| 欧美一级搡bbbb搡bbbb| av亚洲产国偷v产偷v自拍| 日韩精品一区第一页| 中文字幕日韩一区二区| 日韩丝袜美女视频| 99re热这里只有精品视频| 免费观看在线色综合| 国产精品白丝在线| 欧美一级欧美三级在线观看| 99精品欧美一区二区三区小说 | 亚洲线精品一区二区三区八戒| 日韩精品一区二区三区在线| 99re热视频精品| 精品一区二区三区香蕉蜜桃| 一区二区三区日本| 国产亚洲精品超碰| 欧美日韩高清在线| 99re66热这里只有精品3直播 | 亚洲丝袜另类动漫二区| 精品久久久久久无| 欧美亚洲高清一区| 成人中文字幕电影| 日韩av中文在线观看| 中文字幕在线观看一区| 精品久久久久久最新网址| 在线观看不卡视频| 国产不卡视频在线观看| 日本视频在线一区| 亚洲精品免费电影| 国产精品三级在线观看| 欧美成人高清电影在线| 欧美日韩精品欧美日韩精品一| 91亚洲精品久久久蜜桃网站 | 欧美日韩国产综合久久| 成人av电影在线网| 国产一区欧美一区| 日本免费新一区视频| 亚洲成人免费视频| 亚洲男同性恋视频| 欧美韩国日本综合| 久久久欧美精品sm网站| 日韩午夜在线观看视频| 欧美日韩黄色一区二区| 在线中文字幕不卡| 91丨porny丨在线| 成人综合在线视频| 国产成人免费视频精品含羞草妖精| 麻豆精品视频在线观看| 日本不卡1234视频| 亚洲成人一区二区在线观看| 亚洲午夜久久久久久久久久久| 亚洲色图制服丝袜| 中文字幕av在线一区二区三区| 久久人人超碰精品| 337p粉嫩大胆噜噜噜噜噜91av | 国产一区二区电影| 精品一区在线看| 另类小说色综合网站| 美女脱光内衣内裤视频久久影院| 丝袜美腿成人在线| 视频在线观看国产精品| 午夜精品久久久久久久久久久 | 亚洲福利国产精品| 一区二区三区免费在线观看| 亚洲免费观看视频| 亚洲精品国产a| 一区二区三区四区精品在线视频| 亚洲欧美乱综合| 亚洲欧美偷拍三级| 亚洲精品日韩综合观看成人91| 亚洲天堂a在线| 亚洲精品国产一区二区三区四区在线| 亚洲三级久久久| 亚洲精品视频观看| 亚洲成人免费看| 奇米色777欧美一区二区| 免费不卡在线观看| 精品无人码麻豆乱码1区2区| 国内精品伊人久久久久av影院| 国产在线视频精品一区| 国产不卡一区视频| 91在线观看免费视频| 欧美在线999| 3atv一区二区三区| 精品美女被调教视频大全网站| 欧美精品一区二区三区视频| 久久精品在这里| 亚洲欧洲日韩av| 亚洲最大成人综合| 日本怡春院一区二区| 激情综合一区二区三区| 丰满岳乱妇一区二区三区| 成人精品一区二区三区中文字幕 | 2021中文字幕一区亚洲| 国产嫩草影院久久久久| 亚洲视频在线一区观看| 性做久久久久久| 美女视频一区二区| 国产很黄免费观看久久| 91热门视频在线观看| 欧美日韩免费一区二区三区| 日韩欧美一区二区视频| 国产日本欧美一区二区| 亚洲免费在线播放| 天天做天天摸天天爽国产一区 | 99vv1com这只有精品| 欧美三级韩国三级日本三斤| 欧美电影免费观看高清完整版在| 国产日产欧美精品一区二区三区| 亚洲男人的天堂网| 美女在线一区二区| 成人黄色小视频在线观看| 欧美性受极品xxxx喷水| 精品国产乱码久久| 亚洲日本免费电影| 日韩av不卡在线观看| 国产成人精品免费视频网站| 在线观看视频欧美| 精品国产一区久久| 亚洲精品自拍动漫在线| 久久福利视频一区二区| 99久久精品国产网站| 欧美一区二区私人影院日本| 国产精品私人自拍| 日日夜夜精品免费视频| 成人一区二区三区中文字幕| 欧美日韩亚洲综合一区| 久久久国产一区二区三区四区小说| 亚洲免费在线视频一区 二区| 美国欧美日韩国产在线播放| av不卡免费在线观看| 日韩欧美资源站| 亚洲精品视频一区| 国产剧情一区在线| 欧美日韩一区二区三区高清| 国产亚洲一区字幕| 图片区小说区国产精品视频| 东方aⅴ免费观看久久av| 在线不卡一区二区| 国产精品成人一区二区三区夜夜夜| 日本亚洲最大的色成网站www| 成人av在线网站| 日韩午夜av一区| 亚洲综合色网站| 成人av网站大全| 久久这里只有精品视频网| 亚洲国产精品自拍| 成人a免费在线看| 精品国产三级a在线观看| 亚洲小少妇裸体bbw| 成人国产精品免费网站| 欧美大片一区二区| 亚洲福利视频一区二区| 99久久精品国产麻豆演员表| 久久天天做天天爱综合色| 亚洲成人777| 色综合婷婷久久| 欧美国产一区二区| 精品综合久久久久久8888| 欧美日韩中文精品| 日韩美女视频一区| 国产成人亚洲综合a∨婷婷图片 | 欧美成人午夜电影| 婷婷开心激情综合| 色国产精品一区在线观看| 国产精品高清亚洲| 国产精品1024久久|